Momenta Pharmaceuticals (Nasdaq:MNTA) is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.
Recent Mentions on Fool.com
- Ignore Copaxone: Momenta Pharmaceuticals Still a Buy
- Why Gentiva Health Services, Clovis Oncology, and Momenta Pharmaceuticals Are Today's 3 Best Stocks
- Why Shares of Momenta Pharmaceuticals, Inc. Got Their Mojo Back Today
- Why Momenta Pharmaceuticals, Inc. Shares Sank
- Teva's Copaxone: Perspectives From a Patient and Investor